Merck to acquire Harpoon Therapeutics for $680m to strengthen oncology pipeline

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Harpoon Therapeutics, Inc. (Nasdaq: HARP) have entered a definitive agreement where Merck ... Read More